Discovery & Development

Experts from Axolabs GmbH and Bruker Daltonics explain the benefits behind mass spectrometry for oligonucleotides in drug discovery

Researchers genetically modify chickens to build bird-flu resistance – read more here.

Almirall’s humanized monoclonal antibody treatment for psoriasis brings positivity for patients

Why small molecule microarrays are leading the way in small molecule drug discovery

Scientists unearth new molecular targets on AT1R that could lead to improved drugs for heart disease

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Researchers are working on ways to introduce nanoscale artificial life-forms to viruses with the aim of mimicking the human immune system

Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?

New antibiotic candidate Clovibactin eliminates bacteria without developing resistance

Will our generation be the last to face untreatable Alzheimer’s disease? With predictive biomarkers and active immunotherapies, just maybe.